Evidence map›Paper›PMID 41937695›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Stimuli-Responsive Silsesquioxane Nanozymes for Organocatalysis in Water and Prodrug Activation in Cells.

Rabia Zahid, Ariadna Lázaro, Guillermo Moreno-Alcántar, María Sancho-Albero, Pierre Picchetti

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rabia ZahidInstitute of Nanotechnology (INT), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.ORCID 0009-0003-8634-4073
Ariadna LázaroInstitute of Functional Interfaces (IFG), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.ORCID 0000-0003-4064-3257
Guillermo Moreno-AlcántarCenter For Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Donostia-San Sebastian, Spain.ORCID 0000-0001-9836-4694
María Sancho-AlberoInstituto De Nanociencia y Materiales De Argaón (INMA), CISC-Universidad De Zaragoza, Zaragoza, Spain.ORCID 0000-0001-8762-5457
Pierre PicchettiInstitute of Nanotechnology (INT), Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.ORCID 0000-0002-0689-5998

Funding

AECC POST234966SANCCatedra SAMCA (NAIVE project)ESF+Fonds der Chemischen Industrie (FCI, Liebig Fellowship) RYC2024-048755-IMCIN/AEI/ 10.13039/501100011033Scientific Services of the Aragon Institute of Health Sciences (IACS)Spanish Ministry of Science, Innovation and Universities from the Spanish Government PID2023-148732NB-I00the Spanish Ministry of Science, Innovation and Universities from the Spanish Government for a Ramón y Cajal Fellowship RYC2024-050017-I
6 · The paper itself

Abstract

Synthetic nanozymes have emerged as promising alternatives to natural enzymes for catalytic and therapeutic applications, yet their limited stability, aqueous compatibility, and catalytic scope impede broader utilization. Here, we report a mild, one-step sol-gel synthesis that yields ultrasmall, water-stable octa-amino silsesquioxanes functioning as metal-free nanozymes. These minimalistic nanostructures exhibit aldolase-like organocatalytic activity in water and enable dynamic, stimuli-responsive modulation of catalysis through reversible supramolecular aggregation and disaggregation triggered by specific chemical inputs, thus forming a multifunctional platform for tunable catalysis and biomedical applications. Structural simplicity, stability, and functional versatility together permit tunable, enzyme-like catalysis in water without auxiliary surfactants or phase-transfer additives. Furthermore, the nanozymes display high biocompatibility and efficient cellular internalization, enabling their use in living cells, for instance, as intracellular prodrug activators via retro-aldol activation of a doxorubicin prodrug in human glioblastoma and metastatic melanoma cells, resulting in selective cytotoxicity. This system provides a cost-effective, sustainable, and scalable platform for water-compatible, metal-free organocatalysis that bridges abiotic catalysis and biological function. These findings demonstrate how rationally designed silsesquioxane frameworks can emulate natural enzyme reactivity while integrating adaptive, stimuli-responsive behavior, broadening the applicability of synthetic nanozymes to catalytic and therapeutic contexts.

Indexed as

NanostructuresOrganosilicon CompoundsProdrugsWaterCatalysisCell Line, TumorDoxorubicinHumansDoxorubicinOrganosilicon CompoundsProdrugsWaterenzyme‐mimicnanozymeorganocatalysissol–gelstimuli‐responsive

Identifiers

PMID41937695
PMCPMC13182218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.